Dr. Heather Wakelee, MD, FASCO, is a leading oncologist and physician-scientist at Stanford Medicine whose career has been dedicated to improving treatment and outcomes for people with lung cancer. As Deputy Director of the Stanford Cancer Institute and Chief of the Division of Oncology, she combines clinical care, research, education, and leadership in one of the most rapidly evolving areas of modern medicine.
Wakelee has developed particular expertise in thoracic oncology, with a focus on lung cancer. Her work has contributed to the growing understanding of how different forms of lung cancer can be treated with increasingly personalized approaches. Rather than relying on a single treatment strategy, modern lung-cancer care can involve combinations of targeted therapies, immunotherapy, chemotherapy, and other approaches selected according to the characteristics of an individual patient’s disease.
Her career has been especially notable for connecting clinical research with improvements in patient care. Through clinical trials and research programs, Wakelee has helped investigate new approaches for patients with lung cancer, including treatments designed to improve outcomes for people with both early-stage and advanced disease.
In 2026, her contributions received significant recognition when she was honored with a Giants of Cancer Care award in the Thoracic Malignancies category. The award recognizes oncology leaders whose scientific discoveries, clinical innovation, and commitment to patients have helped transform cancer treatment. Stanford Cancer Institute highlighted Wakelee’s leadership in advancing lung-cancer treatment and improving patient care.
Her leadership at Stanford is another important part of her work. As Chief of the Division of Oncology, Wakelee helps guide physicians and researchers working across different areas of cancer medicine. Her position also allows her to contribute to the development of new clinical research and to the education of future oncology specialists.
One of the most important changes in lung-cancer medicine during recent years has been the movement toward precision treatment. Advances in molecular testing have allowed doctors to better understand the biological characteristics of tumors and identify patients who may benefit from specific therapies. Wakelee’s work has been closely connected to this changing landscape of personalized cancer care.
She has also been involved in research examining how new therapies can be incorporated into treatment earlier in the course of disease. This is significant because advances in cancer treatment are not only about helping patients whose disease has already progressed; researchers are increasingly investigating ways to prevent recurrence and improve long-term survival after initial treatment.
Wakelee’s career also reflects the importance of clinical trials in moving cancer treatment forward. Promising treatments must be carefully studied before they can become part of routine medical care. Physicians who participate in this process help bridge the gap between laboratory discoveries and treatments that patients can actually receive.
Beyond research and clinical medicine, Wakelee has been recognized for her commitment to patients and to the broader oncology community. Her leadership provides an example of how physicians can contribute not only through individual patient care but also by helping shape the direction of cancer research and medical education.
What makes Dr. Heather Wakelee particularly compelling for a Movers and Shakers profile is the combination of her clinical expertise, research leadership, and commitment to advancing lung-cancer treatment. Her 2026 Giants of Cancer Care recognition represents another milestone in a career focused on improving the lives of people affected by cancer.
As lung-cancer treatment continues to become more personalized and sophisticated, physicians such as Wakelee are helping determine what the next generation of care will look like. Through research, clinical innovation, leadership, and patient-centered medicine, Dr. Heather Wakelee continues to make a meaningful contribution to the fight against lung cancer.
